Skip to main content
Erschienen in: Reactions Weekly 1/2017

01.06.2017 | Case report

Prednisolone

Steroid-induced diabetes: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Beynon C, et al. Successful Treatment of Autoimmune Disease-Associated Pyoderma Gangrenosum with the IL-1 Receptor Antagonist Anakinra: A Case Series of 3 Patients. JCR: Journal of Clinical Rheumatology 23: 181-183, No. 3, Apr 2017 - United Kingdom Beynon C, et al. Successful Treatment of Autoimmune Disease-Associated Pyoderma Gangrenosum with the IL-1 Receptor Antagonist Anakinra: A Case Series of 3 Patients. JCR: Journal of Clinical Rheumatology 23: 181-183, No. 3, Apr 2017 - United Kingdom
Metadaten
Titel
Prednisolone
Steroid-induced diabetes: case report
Publikationsdatum
01.06.2017
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2017
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-017-31284-x

Weitere Artikel der Ausgabe 1/2017

Reactions Weekly 1/2017 Zur Ausgabe

Case report

Gefitinib

Case report

Prednisone

Case report

Cyproheptadine

Case report

Alectinib